Richard Pzena
Pzena Investment Management
Richard Pzena JAZZ PHARMACEUTICALS PLC stake
total: 584
Pzena Investment Management JAZZ trades
- Total transactions:
- 6
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2021 Q2
- Held for:
- 2 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Richard Pzena doesn't hold any JAZZ PHARMACEUTICALS PLC (JAZZ) shares. To date, the estimated cost basis is nearly $177.39 for "buy" trades and estimated average "sell" price is $129.96. Pzena Investment Management first purchased JAZZ in 2020 Q1, initially acquiring 6,098 shares. Richard Pzena later completely sold out the position and invested in JAZZ PHARMACEUTICALS PLC again in 2021 Q2. Since the initial investment in JAZZ PHARMACEUTICALS PLC (JAZZ), Pzena Investment Management has made 5 more transactions.
When did Richard Pzena sell JAZZ PHARMACEUTICALS PLC (JAZZ)?
Richard Pzena sold off the entire JAZZ PHARMACEUTICALS PLC (JAZZ) position in 2021 Q4.
When did Richard Pzena buy JAZZ PHARMACEUTICALS PLC (JAZZ)?
Richard Pzena first invested in JAZZ PHARMACEUTICALS PLC (JAZZ) in 2020 Q1 at the reported quarter-end price of $99.70 per share.
What's the cost basis of Pzena Investment Management's JAZZ stake?
The estimated cost basis for JAZZ PHARMACEUTICALS PLC (JAZZ) stake is around $177.39 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $177.39
- Weighted AVG sell price:
- $129.96
Richard Pzena's historical trades in JAZZ PHARMACEUTICALS PLC
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$129.96
|
|
-100% (-1,562)
|
-0%
|
|
2021 Q3
|
0.00%
|
1,562
|
$129.96
|
$203,000
|
+1.03% (+16)
|
+0%
|
|
2021 Q2
|
0.00%
|
1,546
|
$177.88
|
$275,000
|
new
|
+0%
|
|
2020 Q3
|
0.00%
|
$110.27
|
-100% (-4,897)
|
|||
|
2020 Q2
|
0.00%
|
$110.27
|
-19.69% (-1,201)
|
|||
|
2020 Q1
|
0.00%
|
$99.70
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.